Advertisement

Molecular Medicine

, Volume 10, Issue 7–12, pp 112–116 | Cite as

SV40-Immortalized Human Fibroblasts as a Source of SV40 Infectious Virions

  • Cristina Morelli
  • Federica Barbisan
  • Laura Iaccheri
  • Mauro Tognon
Articles

Abstract

Human fibroblasts immortalized by Simian Virus 40 (SV40) are widely employed for cell and molecular biology model of study. Indeed, SV40 transmission to humans was believed to occur only under exceptional situations. The oncogenic potential of SV40 in laboratory animals is well established, whereas its involvement in human carcinogenesis is still a matter of active investigations. A recent report links SV40 exposure with the development of a brain tumor in a laboratory researcher. In previous studies, episomal viral DNA was detected in SV40 stably transformed and immortalized fibroblast cell lines. In this study, we report molecular and biological characterizations of SV40 DNA in human fibroblast cells. Our results indicate that SV40 is able to establish a persistent infection in long-term immortalized human fibroblasts, resulting in the production of an infectious viral progeny, which is able to infect both monkey and human cells. These data indicate that SV40-immortalized human fibroblasts may represent a source of SV40 infection. To avoid the SV40 infection, careful attention should be given by operators to this SV40-cell model of study.

Notes

Acknowledgments

This study was granted by Associazione Italiana per la Ricerca sul Cancro and M.I.U.R. Cofin and local projects. Laura Iaccheri was supported by a fellowship from the Fondazione Cassa di Risparmio di Cento.

References

  1. 1.
    Arlington AS, Moore MS, Butel JS. (2004) SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene 23:2231–5.CrossRefGoogle Scholar
  2. 2.
    Barbanti-Brodano G et al. (2004) Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 318:1–9.CrossRefGoogle Scholar
  3. 3.
    Shah K, Nathanson N. (1976) Human exposure to SV40: review and comment. Am. J. Epidemiol. 103:1–12.CrossRefGoogle Scholar
  4. 4.
    Carbone M et al. (1997) Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med. 3:908–12.CrossRefGoogle Scholar
  5. 5.
    Ferber D. (2002) Virology. Monkey virus link to cancer grows stronger. Science 296:1012–5.CrossRefGoogle Scholar
  6. 6.
    Strickler HD et al. (1998) Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 279:292–5.CrossRefGoogle Scholar
  7. 7.
    Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB. (2002) Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol. 13:2320–30.CrossRefGoogle Scholar
  8. 8.
    Butel JS, Lednicky JA. (1999) Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91:119–34.CrossRefGoogle Scholar
  9. 9.
    Barbanti-Brodano G et al. (1998) BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv. Virus Res. 50:69–99.CrossRefGoogle Scholar
  10. 10.
    Jasani B et al. (2001) Association of SV40 with human tumours. Semin. Cancer Biol. 11:49–61.CrossRefGoogle Scholar
  11. 11.
    Garcea RL, Imperiale MJ. (2003) Simian virus 40 infection of humans. J. Virol. 77:5039–45.CrossRefGoogle Scholar
  12. 12.
    Jafar S, Rodriguez-Barradas M, Graham DY, Butel JS. (1998) Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J. Med. Virol. 54:276–84.CrossRefGoogle Scholar
  13. 13.
    Basetse HR, Lecatsas G, Gerber LJ. (2002) An investigation of the occurrence of SV40 antibodies in South Africa. S. Afr. Med. J. 92:825–8.PubMedGoogle Scholar
  14. 14.
    Bright RK, Kimchi ET, Shearer MH, Kennedy RC, Pass HI. (2002) SV40 Tagspecific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol. Immunother. 50:682–90.CrossRefGoogle Scholar
  15. 15.
    O’Neill FJ, Carney H, Hu Y. (1998) Host range analysis of simian virus 40, BK virus and chimeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells. Dev. Biol. Stand. 94:191–205.PubMedGoogle Scholar
  16. 16.
    O’Neill FJ, Carroll D. (1981) Amplification of papovavirus defectives during serial low multiplicity infections. Virology 112:800–3.CrossRefGoogle Scholar
  17. 17.
    Bocchetta M et al. (2000) Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl. Acad. Sci. U.S.A. 97:10214–9.CrossRefGoogle Scholar
  18. 18.
    Cacciotti P et al. (2001) SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc. Natl. Acad. Sci. U.S.A. 98:12032–7.CrossRefGoogle Scholar
  19. 19.
    Shay JW, Wright WE. (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184:109–18.CrossRefGoogle Scholar
  20. 20.
    Huschtscha LI, Holliday R. (1983) Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J. Cell Sci. 63:77–99.PubMedGoogle Scholar
  21. 21.
    Hara H, Kaji H. (1987) Random integration of SV40 in SV40-transformed, immortalized human fibroblasts. Exp. Cell Res. 168:531–8.CrossRefGoogle Scholar
  22. 22.
    Huang KC, Yamasaki EF, Snapka RM. (1999) Maintenance of episomal SV40 genomes in GM637 human fibroblasts. Virology 262:457–69.CrossRefGoogle Scholar
  23. 23.
    Forsman ZH et al. (2004) Phylogenetic analysis of polyomavirus simian virus 40 from monkeys and humans reveals genetic variation. J. Virol. 78:9306–16.CrossRefGoogle Scholar
  24. 24.
    Morelli C, Barbisan F, Iaccheri L, Tognon M. (2004) Simian virus 40 persistent infection in long-term immortalized human fibroblast cell lines. J. Neurovirol. 10:250–4.CrossRefGoogle Scholar
  25. 25.
    Barbanti-Brodano G et al. (2004) Reactivation of infectious simian virus 40 from normal human tissues. J. Neurovirol. 10:199–205.CrossRefGoogle Scholar
  26. 26.
    Martini F et al. (2002) Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 94:1037–48.CrossRefGoogle Scholar
  27. 27.
    Clever J, Yamada M, Kasamatsu H. (1991) Import of simian virus 40 virions through nuclear pore complexes. Proc. Natl. Acad. Sci. U.S.A. 88:7333–7.CrossRefGoogle Scholar
  28. 28.
    Martini F et al. (1996) SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res. 56:4820–5.PubMedGoogle Scholar
  29. 29.
    Carbone M, Rizzo P, Pass HI. (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15:1877–88.CrossRefGoogle Scholar
  30. 30.
    Vastag B. (2002) Sewage yields clues to SV40 transmission. JAMA 288:1337–8.CrossRefGoogle Scholar
  31. 31.
    Sainis L, Angelidis C, Pagoulatos GN, Lazaridis L. (2000) HSC70 interactions with SV40 viral proteins differ between permissive and nonpermissive mammalian cells. Cell Stress Chaperones 5:132–8.CrossRefGoogle Scholar
  32. 32.
    Klawitz I, Preuss U, Scheidtmann KH. (2001) Interaction of SV40 large T antigen with components of the nucleo/cytoskeleton. Int. J. Oncol. 19:1325–32.PubMedGoogle Scholar
  33. 33.
    Li PP, Nakanishi A, Clark SW, Kasamatsu H. (2002) Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 99:1353–8.CrossRefGoogle Scholar
  34. 34.
    Nakanishi A, Shum D, Morioka H, Otsuka E, Kasamatsu H. (2002) Interaction of the Vp3 nuclear localization signal with the importin alpha 2/beta heterodimer directs nuclear entry of infecting simian virus 40. J. Virol. 76:9368–77.CrossRefGoogle Scholar
  35. 35.
    Pelkmans L, Puntener D, Helenius A. (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296:535–9.CrossRefGoogle Scholar
  36. 36.
    Gordon-Shaag A, Ben-Nun-Shaul O, Roitman V, Yosef Y, Oppenheim A. (2002) Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. J. Virol. 76:5915–24.CrossRefGoogle Scholar
  37. 37.
    Milavetz BI. (2002) SP1 and AP-1 elements direct chromatin remodeling in SV40 chromosomes during the first 6 hours of infection. Virology 294:170–9.CrossRefGoogle Scholar
  38. 38.
    Cripe TP, Delos SE, Estes PA, Garcea RL. (1995) In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J. Virol. 69:7807–13.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Chromy LR, Pipas JM, Garcea RL. (2003) Chaperone-mediated in vitro assembly of polyomavirus capsids. Proc. Natl. Acad. Sci. U.S.A. 100:10477–82.CrossRefGoogle Scholar
  40. 40.
    Lednicky JA, Butel JS. (2001) Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin Cancer Biol 11:39–47.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2004

Authors and Affiliations

  • Cristina Morelli
    • 1
  • Federica Barbisan
    • 1
  • Laura Iaccheri
    • 1
  • Mauro Tognon
    • 1
  1. 1.Department of Morphology and Embryology, Section of Histology and Embryology, Chair of Applied Biology, School of Medicine, and Center of BiotechnologyUniversity of FerraraFerraraItaly

Personalised recommendations